Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion type Assertion NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_head.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion description "[Our study has implications for miR-375 as a potential target in combination with trastuzumab for treating HER2-positive breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion evidence source_evidence_literature NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion SIO_000772 24571711 NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion wasDerivedFrom befree-20150227 NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.
- NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_assertion wasGeneratedBy ECO_0000203 NP1002390.RAQ-y3zntoiiDflOgGT-KAEIeMn2k44kTMSK4QFjscaBU130_provenance.